Fund profile / France

Lauxera Growth II

Geography: France
Stage: Growth
Fund size: €520M
Focus: Biotech, Diagnostics, Digital Health and MedTech
Signals: Published

N°01 / About

About Lauxera Growth II

Paris and SF-based growth investor backing commercial-stage European healthtech companies expanding into the US. €20M–€50M checks, minority and majority. Anchored by Bpifrance, EIF, Morgan Stanley IM.

N°02 / Thesis

Investment Focus

Location / RegionFrance

Funding StageGrowth

Industry Focus

Biotech

Diagnostics

Digital Health

MedTech

Investor Signals Profile

active

Sweet Spot

FDA-cleared European medtech, US commercial scale, transplant/surgical focus

European healthtech US expansion

growth equity

commercial-stage only

transatlantic bridge

reimbursement-driven markets

medical devices

organ transplant tech

machine perfusion

FDA-cleared scaling

health sovereignty

EU manufacturing

Bullish Signals

90%+ LP re-up rateblog

€520M, broke hard capblog

Morgan Stanley IM, EIF, Bpifrance anchoringblog

2 deals deployed, disciplined pacingblog

$110M Bridge to Life co-lead, Soleuslinkedin

FDA-cleared VitaSmart scaling, complementary assetlinkedin

Sequential deal pace accelerating post-closelinkedin

VitaSmart standout early growth US marketlinkedin

Belzer UW gold standard cold storagelinkedin

Verdot €10M Biopole expansion, 75 jobslinkedin

Health sovereignty, EU manufacturing credibility boostlinkedin

Bpifrance co-backing signals state-level alignmentlinkedin

Contrarian Signals

12–15 company portfolio, high concentrationblog

US M&A market remains choppyblog

No public IRR figures disclosedblog

Organ perfusion niche, regulatory complexity highlinkedin

Founder Do's

Have €5M+ revenue before approaching

Show credible US reimbursement strategy

Be ready for deep US commercial diligence

Open to majority or minority structures

European HQ, US expansion ambition required

FDA clearance or regulatory pathway critical

Large TAM, life-critical applications preferred

Demonstrate early US commercial traction

Highlight European manufacturing/supply chain strength

Founder Don'ts

Don't pitch pre-commercial or early-stage

Don't ignore US market-entry plan

Don't expect light diligence process

Don't lack regulatory/compliance rigor

33 signals on Lauxera Growth II

12 bullish · 4 contrarian · 9 pitch do's · 4 don'ts · 4 GP profiles, each with its source. From €9/month, cancel anytime.

See a signal free View Plans Browse all Signal Profiles →

Facts

Fund Overview

Fund Size€520M

Saves0

Website

People

Key People

Lauxera Capital Partners

Lauxera Capital Partners TeamPartnership Group

Samuel LevyPartner

Pauline RitterPartner

Louis SévinPartner

Backers

Known LPs

European Investment Fund (EIF)Fund-of-Funds

BpifrancePublic / State institution

Morgan Stanley Investment ManagementAsset manager / Investment firm

+4 more LPs in LP Radar

N°04 / See also

Related Funds

Time4 Fund I

Fund size€100M

Location: France
Stage: Pre Seed
Focus: Saas, Climate Sustainability
Manager: Time4 (daphni, Les Déterminés, Live for Good, HEC Paris)

Pre Seed

Saas

Climate Sustainability

Jeito Capital II

Fund size€1B

Location: France
Stage: Late Stage
Focus: Biotech, Therapeutics
Manager: Jeito Capital

Late Stage

Biotech

Therapeutics

Cathay Innovation Fund III

Fund size€1000M

Location: France
Stage: Pre Seed
Focus: Saas, Mobility Transport, Ai Ml, Climate Sustainability
Manager: Denis Barrier, Jacky Abitbol, Daniel Balm

Pre Seed

Saas

Mobility Transport

Ai Ml

Climate Sustainability